Moody’s affirms ‘A1’ rating for Aspirus

 
Moody’s Investors Service has affirmed its “A1” rating for Wausau, Wis.-based Aspirus, affecting $227 million of rated debt.

Advertisement

The affirmation reflects Aspirus’ key credit strengths, including strong operating performance, good balance sheet growth and a moderate comprehensive debt load. Though capital spending will be elevated in the next five years, Moody’s expects cash flow will support this spending.

The rating outlook is stable.

More articles on healthcare finance:

Bankrupt hospital chain’s plan to offload 5 California clinics faces opposition
Attorney general investigating 2 Kansas hospitals that abruptly closed
Trinity Health posts $301M loss in first half of fiscal year

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.